Liling Koh

Liling Koh is the Sr. Director of M&A, BD, and Innovation Cluster Markets at DKSH, where they focus on locating and nurturing commercial partnerships and M&A opportunities in the pharma and biotech sectors across Asia. Previously, Liling served as the Country Director for Pharmaceuticals and Medical Devices at Johnson & Johnson Singapore, leading a team to enhance portfolios and manage key customer relationships. Liling holds a PhD in Bio-Nanotechnology from Imperial College London and has extensive experience in strategic marketing and market access across various regions. Passionate about healthcare, Liling advocates for greater mental health awareness and seeks to unlock potential in Southeast Asia's evolving market.